Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Non-Current Assets

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Total Non-Current Assets History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Assets ₹5,630 Cr₹5,881 Cr₹6,840 Cr₹7,115 Cr₹6,709 Cr

What is the latest Total Non-Current Assets ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Non-Current Assets ratio of GLENMARK PHARMACEUTICALS is ₹5,630 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Assets
Mar2025₹5,630 Cr
Mar2024₹5,881 Cr
Mar2023₹6,840 Cr
Mar2022₹7,115 Cr
Mar2021₹6,709 Cr

How is Total Non-Current Assets of GLENMARK PHARMACEUTICALS Trending?

Years Total Non-Current Assets % Change
Mar2025 ₹5,630 Cr
-4.27
Mar2024 ₹5,881 Cr
-14.03
Mar2023 ₹6,840 Cr
-3.86
Mar2022 ₹7,115 Cr
6.04
Mar2021 ₹6,709 Cr -

Compare Total Non-Current Assets of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹60,325.9 Cr 4.9% 6% 63.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 0.3% 9% 8.6% Stock Analytics
DIVIS LABORATORIES ₹170,237.0 Cr 1.9% 5.9% 12.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 0.6% 9.5% 45% Stock Analytics
CIPLA ₹108,861.0 Cr 1.6% 1.8% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr -1.5% 5.7% 14.5% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

4.9%

6%

63.6%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses